B.Riley cuts AXT stock price target on China export risks
B.Riley reduced its price target for AXT, Inc. (NASDAQ:AXTI) to $43.00 from $56.00, citing risks from U.S.-China tech tensions. The company's stock has fallen 69% in six months but gained 275% over a year. AXT reported Q3 revenue of $73.4M, up 162% YoY, with strong earnings. B.Riley warns of potential fragility in export permits and competition from non-Chinese suppliers.
How this was made
The 30-second read
Why it matters
The key trading takeaway is a valuation and risk re-rating from a major analyst, anchored to export-permit fragility and potential customer shifts toward non-Chinese suppliers.
Market read
A sell-side target reduction tied to export-permit risk can influence positioning in AXT and related semiconductor-material supply-chain trades.
What to watch
The article notes permit improvement after February 2025 export-control changes; if that improvement persists, the market may over-discount the worst-case Washington-Beijing retaliation scenario.
Background
AXT manufactures indium phosphide substrates in China and needs Beijing export permits for shipments abroad; B.Riley links the valuation to the durability of permit availability.
Ticker impact
B.Riley cut AXT’s price target to $43 from $56, citing AXT’s China export-permit dependence for indium phosphide substrates.
Likely near-term pressure as the market reprices risk around export permits and customer qualification of non-Chinese suppliers.
The article centers on a fresh sell-side target reduction tied to a specific operational bottleneck (China export permits) and a scenario where Washington tightens and Beijing slows permits again.
Market effects
Highlights supply-chain and export-control risk for photonics/semiconductor materials tied to China-controlled inputs, which can pressure sentiment across adjacent substrate and component names.
US-listed semiconductor supply-chain equities may see correlated risk-off moves on renewed export-permit uncertainty.
Reinforces that US-China technology tensions can directly affect cross-border shipments of critical semiconductor materials, impacting global AI supply chains.
Counterpoint
Despite the target cut, the company reported record Q3 revenue and a large backlog, suggesting demand strength may offset some permit risk if guidance holds.
Key entities
- companyAXT, Inc.
NASDAQ-listed indium phosphide substrate maker whose shipments depend on China export permits.
- analyst_firmB.Riley
Cut AXT’s price target to $43 from $56 while keeping a Neutral rating.
- customerLumentum
Named as a customer that could qualify non-Chinese suppliers if export permits tighten.
- customerCoherent
Named as a customer that could qualify non-Chinese suppliers if export permits tighten.
- supplierFreiberger
Germany-based non-Chinese supplier mentioned as a potential alternative.



